miR-532-5p调控RUNX3表达介导胃癌发生发展的分子机制

基本信息
批准号:81201935
项目类别:青年科学基金项目
资助金额:23.00
负责人:徐霞
学科分类:
依托单位:山东大学
批准年份:2012
结题年份:2015
起止时间:2013-01-01 - 2015-12-31
项目状态: 已结题
项目参与者:张英杰,吴晓娟,崔福爱,吴伟芳,冯一民,臧文
关键词:
胃癌miR5325pRUNX3
结项摘要

RUNX3 functions as an important transcription factor regulating the growth of gastric epithelia cell. RUNX3 is downregulated or absent in 50-70% human primary gastric cancer and gastric cancer cell lines, partly due to loss of allele heterozygosity and hypermethylation in RUNX3 gene promoter. So, further studies are necessary to interpret the mechanism of RUNX3 inactivation. MiRNA produces a marked effect by inhibiting protein synthesis at post-transcription level. Bioinformatics analysis showed that miRNA-532-5p binds to the RUNX3 3' untranslated regions perfectly. During previous studies, we first found that miR-532-5p was highly expressed in several human gastric cancer cell lines, and was correlated negatively with the level of RUNX3 protein. Moreover, RUNX3 protein level was downregulated by transfection of miR-532-5p eukaryotic expressing vector or specific miR-532-5p mimics, but upregulated by specific miR-532-5p inhibitor. In addition, the miR-532-5p mimics could apparently decrease the apoptosis of the gastric cancer cell detected by flowcytometry. Based on these results, further studies include: 1)explore the negative regulation mechanism of miR-532-5p on RUNX3 expression; 2)interpret the biological functions and related mechanism of miR-532-5p on the gastric cancer cells in vitro; 3)assess the functions of miR-532-5p and its regulation on RUNX3 in primary gastric cancer specimens and nude mouse transplantation tumor.

RUNX3是调节胃上皮细胞生长的重要转录因子,50-70%的人类原发性胃癌及多种胃癌细胞系中Runx3表达下调或缺失。等位基因杂合性缺失和启动子过度甲基化尚不能完全解释RUNX3失活。miRNA在转录后基因表达调控中发挥重要作用。生物信息学分析显示miR-532-5p可以结合在RUNX3 3'非翻译区。申请者首次发现,miR-532-5p在多株人胃癌细胞中高表达,与RUNX3蛋白表达呈负相关。转染miR-532-5p表达质粒或mimics可以下调RUNX3蛋白表达,而inhibitor则上调RUNX3表达。流式分析结果表明mimics可以减少胃癌细胞的凋亡率。本课题拟在前期研究基础上1)解析miR-532-5p负性调节RUNX3表达的分子机制;2)阐明miR-532-5p对胃癌细胞生物学功能的影响及其分子机制;3)临床标本及裸鼠成瘤实验评价miR-532-5p的功能及对RUNX3的调控。

项目摘要

深入研究胃癌发生、发展及其转归的分子机制是寻找有效的诊断标志和改进治疗方案的根本。近年来,miRNA的发现及其研究领域的兴起开启了胃癌发生发展机制研究的新篇章。.miR-532-5p位于人类染色体Xp11.23,成熟序列由22个核苷酸构成。生物信息学软件ClustalW serve分析不同物种miR-532-5p 序列显示,物种间成熟序列极其保守,表明miR-532-5p在物种进化中发挥重要作用。miR-532-5p与人类胃癌的关系在本课题之前尚未见报道,因此我们的研究旨在阐明miR-532-5p对人类胃癌的影响及其相关的调控机制。.瞬时转染miR-532-5p特异性mimics和稳定过表达miR-532-5p在体外能够明显增强胃癌细胞的克隆形成和迁移能力,减少G1期细胞的比例和凋亡细胞比例,在体内能够促进裸鼠肺脏转移瘤的形成,使肺组织重量增加,瘤结节数目增多。功能获得实验、功能缺失实验、细胞表达谱分析和裸鼠转移瘤实验均显示miR-532-5p能负性调节转录因子RUNX3及其靶基因的表达,荧光素酶活性分析结果证明RUNX3是miR-532-5p调控的直接靶分子。临床标本检测显示miR-532-5p在近一半的原发性胃癌组织中过表达。这些研究结果说明,miR-532-5p能够增强胃癌细胞的生长、迁移和侵袭能力而发挥致癌性miRNA的作用,为解析胃癌发生和侵袭转移的分子机制提供了必要的理论支持。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway

MiR-145 inhibits human colorectal cancer cell migration and invasion via PAK4-dependent pathway

DOI:10.1002/cam4.1029.
发表时间:2017
2

Inhibiting miR-22 Alleviates Cardiac Dysfunction by Regulating Sirt1 in Septic Cardiomyopathy

Inhibiting miR-22 Alleviates Cardiac Dysfunction by Regulating Sirt1 in Septic Cardiomyopathy

DOI:10.3389/fcell.2021.650666
发表时间:2021
3

下调SNHG16对胃癌细胞HGC-27细胞周期的影响

下调SNHG16对胃癌细胞HGC-27细胞周期的影响

DOI:
发表时间:2017
4

MiR-516a-5p inhibits the proliferation of non-small cell lung cancer by targeting HIST3H2A

MiR-516a-5p inhibits the proliferation of non-small cell lung cancer by targeting HIST3H2A

DOI:10.1177/2058738419841481
发表时间:2019
5

Inhibition of miR-193a-3p protects human umbilical vein endothelial cells against intermittent hypoxia-induced endothelial injury by targeting FAIM2

Inhibition of miR-193a-3p protects human umbilical vein endothelial cells against intermittent hypoxia-induced endothelial injury by targeting FAIM2

DOI:
发表时间:2020

徐霞的其他基金

相似国自然基金

1

特异性胃癌标记物HOXA13的验证及其调控RUNX3表达诱导胃癌发生的机制研究

批准号:81172330
批准年份:2011
负责人:周崇治
学科分类:H1813
资助金额:54.00
项目类别:面上项目
2

RUNX3抑制人胃癌细胞中survivin基因表达的分子机制研究

批准号:30800406
批准年份:2008
负责人:刘志方
学科分类:H1802
资助金额:20.00
项目类别:青年科学基金项目
3

HINT1调控DSB修复参与胃癌发生发展分子机制研究

批准号:81201882
批准年份:2012
负责人:魏晓为
学科分类:H1802
资助金额:23.00
项目类别:青年科学基金项目
4

新型抑癌基因Runx3抑制胃癌的分子机制研究

批准号:30400540
批准年份:2004
负责人:郭长存
学科分类:H1819
资助金额:21.00
项目类别:青年科学基金项目